3648 results for «2509»
3648 results
Featured Cases - Pulmonary valve intervention
26 Nov 2024 – From PCR London Valves 2024
Explore this session featuring a selection of compelling clinical cases from PCR London Valves 2024, focusing on innovative percutaneous interventions for complex pulmonary valve pathologies. Discover how clinicians are simplifying the challenge of treating dilated main pulmonary arteries, dealing with premature balloon rupture, and tackling giant...
Featured cases - New TMVR devices
25 Nov 2024 – From PCR London Valves 2024
Dive into the latest advancements in transcatheter mitral valve replacement (TMVR) technologies with this featured cases session from PCR London Valves 2024. Explore innovative approaches to address complex mitral valve pathologies, including the use of a combined valvulopathy with severe mitral regurgitation and moderate stenosis, the...
Featured Cases - TAVI in SAVR (Part 2)
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address challenging scenarios in patients with prior surgical aortic valve replacement (SAVR). Gain insights into managing severe aortic regurgitation in degenerated homografts, stopping torrential aortic regurgitation...
Rapid-Fire - TAVI Complications (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Delve into the world of transcatheter aortic valve implantation (TAVI) complications in this rapid-fire session from PCR London Valves 2024. Witness captivating case studies that highlight the challenges and resolutions encountered during TAVI procedures. From anemia-induced valve thrombosis to acute aortic regurgitation during balloon expansion, this...
Stroke prevention - featured cases
26 Nov 2024 – From PCR London Valves 2024
Dive into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of various stroke prevention strategies during structural heart interventions. Explore techniques such as snaring-assisted TAVR under cerebral embolic protection, single-side access for cerebral embolic protection devices, and the integration...
Featured Research - Aortic valve (Part 9)
25 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve disease in this featured session, comprising selected abstracts from PCR London Valves 2024. Explore topics ranging from lower extremity dysfunction after transfemoral TAVI, gender differences in long-term TAVR outcomes, the impact of left ventricular outflow tract calcification on...
Featured cases - TAVI in aortic regurgitation
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address aortic regurgitation. Gain insights into the management of pure native aortic regurgitation in surgically unfit patients, the treatment of aortic regurgitation in patients with left...
Featured Research - Tricuspid valve (Part 3)
25 Nov 2024 – From PCR London Valves 2024
Dive into the latest advancements in tricuspid valve interventions in this featured research session. Explore the systematic review of novel balloon-expandable valves across different cardiac locations, the impact of transcatheter tricuspid valve repair on patient health status, and the value of the pulmonary artery pulsatility index...
Rapid-Fire - Transcatheter tricuspid valve replacement
25 Nov 2024 – From PCR London Valves 2024
Dive into a rapid-fire session showcasing the latest advancements in transcatheter tricuspid valve replacement (TTVR). Explore a case of using the LuX TTVR system to salvage a single leaflet device attachment TriClip, a unique case combining multiple interventional strategies for severe tricuspid regurgitation, and the first...
Advanced imaging in tricuspid TEER - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:
- A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation
25 Nov 2024 – From PCR London Valves 2024
This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...
Align for the future with the novel balloon expandable Myval transcatheter heart valve series
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....
Unlocking the potential of mitral and tricuspid valves clipping
24 Nov 2024 – From PCR London Valves 2024
This session examines two compelling cases: a 78-year-old woman with paroxysmal atrial fibrillation, chest trauma, an osteoporotic sternum fracture, and NYHA II exertional dyspnoea, and an 82-year-old man with chronic three-vessel coronary artery disease, bradycardic AF, peripheral arterial disease, spinal stenosis, and chronic kidney disease. Through...
Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
Pushing the boundaries to optimise patient outcomes: from planning to success
26 Nov 2024 – From PCR London Valves 2024
Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
